Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis
ESC Heart Failure · 01.06.2025 · 12 (3) · 1535-1538
DOI: 10.1002/ehf2.15168 ↗Kurz gefasst
Editorial in der Zeitschrift ESC Heart Failure, online erschienen am 15.11.2024. Verfasst von Arnold Péter Ráduly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Division of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Biomarkers have long been of major importance in the diagnosis, prognosis, and follow-up of heart failure (HF).Recently, in addition to conventional biomarkers, new types of biomarkers have emerged that are not yet used in the clinical practice and may later become of paramount importance in the long-term management of HF.The aim of this Editorial is to highlight the latest advancements of HF related biomarkers that have been published in ESC Heart Failure.
Autor:innen und Institutionen
- Department of Cardiology, Division of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Zitieren
APA
Ráduly, A. P., Nagy, L., Bódi, B., Papp, Z., & Borbély, A. (2025). Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis. ESC Heart Failure, 12(3), 1535-1538. https://doi.org/10.1002/ehf2.15168
Vancouver
Ráduly AP, Nagy L, Bódi B, Papp Z, Borbély A. Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis. ESC Heart Failure. 2025;12(3):1535-1538. doi:10.1002/ehf2.15168
BibTeX
@article{Rduly2025,
author = {Ráduly, Arnold Péter and Nagy, László and Bódi, Beáta and Papp, Zoltán and Borbély, Attila},
title = {Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis},
journal = {ESC Heart Failure},
year = {2025},
volume = {12},
number = {3},
pages = {1535--1538},
doi = {10.1002/ehf2.15168}
}
EUVIMED